Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	GTPase activator activity	ARHGAP36 TBC1D5 RALGAPB ARHGAP39 GMIP TBC1D16 PLEKHG6 RALBP1 AGAP3	1.35e-04	279	137	9	GO:0005096
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	PLEKHG4 ARHGAP36 TBC1D5 RALGAPB ARHGAP39 GMIP TBC1D16 PLEKHG6 RALBP1 AKAP13 DOCK6 AGAP3	1.98e-04	507	137	12	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	PLEKHG4 ARHGAP36 TBC1D5 RALGAPB ARHGAP39 GMIP TBC1D16 PLEKHG6 RALBP1 AKAP13 DOCK6 AGAP3	1.98e-04	507	137	12	GO:0030695
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC4	2.78e-04	4	137	2	GO:0030197
GeneOntologyMolecularFunction	transcription coregulator binding	PER1 PER3 EHMT1 NR3C2 BSN MAP3K7	4.13e-04	140	137	6	GO:0001221
GeneOntologyMolecularFunction	transcription corepressor binding	PER1 PER3 EHMT1 BSN	7.20e-04	59	137	4	GO:0001222
GeneOntologyBiologicalProcess	positive regulation of GTPase activity	PLEKHG4 TBC1D5 PKP4 RALGAPB GMIP TBC1D16 RALBP1 DOCK6 CX3CL1 AGAP3	6.26e-06	244	139	10	GO:0043547
GeneOntologyBiologicalProcess	regulation of GTPase activity	PLEKHG4 TBC1D5 PKP4 RALGAPB GMIP TBC1D16 RALBP1 RIPOR1 DOCK6 CX3CL1 AGAP3	1.73e-05	335	139	11	GO:0043087
GeneOntologyCellularComponent	Golgi lumen	MUC19 MUC16 MUC12 MUC17 ACAN MUC4 MUC5AC MUC20	6.38e-07	109	138	8	GO:0005796
GeneOntologyCellularComponent	perinuclear region of cytoplasm	ANKRD13B MAPK8IP1 KIF1A HCN4 PKP4 APLP1 MAGEE1 TRIP10 TG PACS1 BPTF AATK NFKBIE OSBPL7 AKAP13 TNKS2 DOCK6 CX3CL1 DMTN	1.25e-05	934	138	19	GO:0048471
GeneOntologyCellularComponent	postsynapse	KIF1A PKP4 SHC4 LRRC4B BCL11A ARHGAP39 MAGEE1 DNAJC6 ITGB4 PDLIM5 SHISA9 CAMKV PIK3C3 ELFN1 CASKIN1 NR3C2 BSN MAP3K7 DMTN	4.10e-05	1018	138	19	GO:0098794
MousePheno	abnormal brain wave pattern	PER1 LRRC4B PER3 ELFN1 SCN10A BSN	9.64e-06	64	108	6	MP:0004994
Domain	SEA	MUC16 MUC12 MUC17 IMPG2	1.44e-05	22	129	4	PF01390
Domain	SEA	MUC16 MUC12 MUC17 IMPG2	1.74e-05	23	129	4	PS50024
Domain	SEA_dom	MUC16 MUC12 MUC17 IMPG2	1.74e-05	23	129	4	IPR000082
Domain	-	ANKRD13B CASKIN1 NFKBIE TONSL EHMT1 AKAP13 TNKS2 HECTD1 AGAP3	5.70e-05	248	129	9	1.25.40.20
Domain	ANK_REPEAT	ANKRD13B MUC16 CASKIN1 NFKBIE TONSL EHMT1 TNKS2 HECTD1 AGAP3	6.65e-05	253	129	9	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKRD13B CASKIN1 NFKBIE TONSL EHMT1 AKAP13 TNKS2 HECTD1 AGAP3	6.85e-05	254	129	9	IPR020683
Domain	ANK_REP_REGION	ANKRD13B MUC16 CASKIN1 NFKBIE TONSL EHMT1 TNKS2 HECTD1 AGAP3	6.85e-05	254	129	9	PS50297
Domain	SEA	MUC16 MUC17 IMPG2	1.11e-04	14	129	3	SM00200
Domain	Cadherin_tail	PCDHA9 PCDHGA7 PCDHGA6 PCDHGA8	1.20e-04	37	129	4	PF15974
Domain	Cadherin_CBD	PCDHA9 PCDHGA7 PCDHGA6 PCDHGA8	1.20e-04	37	129	4	IPR031904
Domain	Ank_2	ANKRD13B CASKIN1 NFKBIE TONSL EHMT1 TNKS2 HECTD1 AGAP3	1.25e-04	215	129	8	PF12796
Domain	-	MUC16 MUC17 IMPG2	1.38e-04	15	129	3	3.30.70.960
Domain	Period_circadian-like_C	PER1 PER3	1.41e-04	3	129	2	IPR022728
Domain	Period_C	PER1 PER3	1.41e-04	3	129	2	PF12114
Domain	VWF_type-D	MUC19 MUC4 MUC5AC	1.69e-04	16	129	3	IPR001846
Domain	VWFD	MUC19 MUC4 MUC5AC	1.69e-04	16	129	3	PS51233
Domain	VWD	MUC19 MUC4 MUC5AC	1.69e-04	16	129	3	SM00216
Domain	VWD	MUC19 MUC4 MUC5AC	1.69e-04	16	129	3	PF00094
Domain	Ank	ANKRD13B CASKIN1 NFKBIE TONSL EHMT1 TNKS2 HECTD1 AGAP3	1.87e-04	228	129	8	PF00023
Domain	Cadherin_C	PCDHA9 PCDHGA7 PCDHGA6 PCDHGA8	1.98e-04	42	129	4	IPR032455
Domain	Cadherin_C_2	PCDHA9 PCDHGA7 PCDHGA6 PCDHGA8	1.98e-04	42	129	4	PF16492
Domain	ANK	ANKRD13B CASKIN1 NFKBIE TONSL EHMT1 TNKS2 HECTD1 AGAP3	3.58e-04	251	129	8	SM00248
Domain	SMAD_FHA_domain	KIF1A DUSP15 SLC4A1AP CHFR	4.55e-04	52	129	4	IPR008984
Domain	Ankyrin_rpt	ANKRD13B CASKIN1 NFKBIE TONSL EHMT1 TNKS2 HECTD1 AGAP3	4.76e-04	262	129	8	IPR002110
Domain	PH_dom-like	MAPK8IP1 KIF1A PLEKHG4 FRMPD1 SHC4 TNS2 PLEKHG6 OSBPL7 AKAP13 AGAP3	7.55e-04	426	129	10	IPR011993
Domain	RhoGAP	ARHGAP36 ARHGAP39 GMIP RALBP1	8.89e-04	62	129	4	SM00324
Domain	FHA	KIF1A SLC4A1AP CHFR	9.29e-04	28	129	3	SM00240
Domain	RhoGAP	ARHGAP36 ARHGAP39 GMIP RALBP1	9.44e-04	63	129	4	PF00620
Domain	Cadherin_CS	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	9.57e-04	109	129	5	IPR020894
Domain	RhoGAP_dom	ARHGAP36 ARHGAP39 GMIP RALBP1	1.00e-03	64	129	4	IPR000198
Domain	RHOGAP	ARHGAP36 ARHGAP39 GMIP RALBP1	1.00e-03	64	129	4	PS50238
Domain	-	ARHGAP36 ARHGAP39 GMIP RALBP1	1.00e-03	64	129	4	1.10.555.10
Domain	Cadherin_2	PCDHA9 PCDHGA7 PCDHGA6 PCDHGA8	1.06e-03	65	129	4	PF08266
Domain	Cadherin_N	PCDHA9 PCDHGA7 PCDHGA6 PCDHGA8	1.06e-03	65	129	4	IPR013164
Domain	CADHERIN_1	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	1.13e-03	113	129	5	PS00232
Domain	Cadherin	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	1.13e-03	113	129	5	PF00028
Domain	CADHERIN_2	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	1.17e-03	114	129	5	PS50268
Domain	-	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	1.17e-03	114	129	5	2.60.40.60
Domain	CA	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	1.22e-03	115	129	5	SM00112
Domain	FHA_DOMAIN	KIF1A SLC4A1AP CHFR	1.26e-03	31	129	3	PS50006
Domain	FHA	KIF1A SLC4A1AP CHFR	1.26e-03	31	129	3	PF00498
Domain	Cadherin-like	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	1.26e-03	116	129	5	IPR015919
Domain	PTEN_C2	TNS2 DNAJC6	1.29e-03	8	129	2	PF10409
Domain	PTEN_C2	TNS2 DNAJC6	1.29e-03	8	129	2	SM01326
Domain	C2_TENSIN	TNS2 DNAJC6	1.29e-03	8	129	2	PS51182
Domain	Tensin_lipid_phosphatase_dom	TNS2 DNAJC6	1.29e-03	8	129	2	IPR029023
Domain	Tensin_C2-dom	TNS2 DNAJC6	1.29e-03	8	129	2	IPR014020
Domain	Cadherin	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	1.36e-03	118	129	5	IPR002126
Domain	-	MAPK8IP1 KIF1A PLEKHG4 SHC4 TNS2 PLEKHG6 OSBPL7 AKAP13 AGAP3	1.59e-03	391	129	9	2.30.29.30
Domain	PPASE_TENSIN	TNS2 DNAJC6	1.65e-03	9	129	2	PS51181
Domain	-	KIF1A SLC4A1AP CHFR	1.95e-03	36	129	3	2.60.200.20
Domain	FHA_dom	KIF1A SLC4A1AP CHFR	1.95e-03	36	129	3	IPR000253
Domain	Znf_PHD-finger	PHRF1 BPTF TRIM28 KDM2B	2.19e-03	79	129	4	IPR019787
Domain	PTB	MAPK8IP1 SHC4 TNS2	2.64e-03	40	129	3	SM00462
Domain	PTB/PI_dom	MAPK8IP1 SHC4 TNS2	2.83e-03	41	129	3	IPR006020
Domain	C8	MUC19 MUC5AC	2.99e-03	12	129	2	PF08742
Domain	TIL	MUC19 MUC5AC	2.99e-03	12	129	2	PF01826
Domain	Rho_GTPase_activation_prot	ARHGAP36 ARHGAP39 GMIP RALBP1	3.24e-03	88	129	4	IPR008936
Domain	PHD	PHRF1 BPTF TRIM28 KDM2B	3.37e-03	89	129	4	SM00249
Domain	Unchr_dom_Cys-rich	MUC19 MUC5AC	3.51e-03	13	129	2	IPR014853
Domain	C8	MUC19 MUC5AC	3.51e-03	13	129	2	SM00832
Domain	Znf_FYVE_PHD	PHRF1 BPTF TRIM28 KDM2B BSN	3.56e-03	147	129	5	IPR011011
Domain	Znf_PHD	PHRF1 BPTF TRIM28 KDM2B	3.65e-03	91	129	4	IPR001965
Domain	-	TNS2 DUSP15 DNAJC6 PTPRC	3.80e-03	92	129	4	3.90.190.10
Domain	TIL_dom	MUC19 MUC5AC	4.08e-03	14	129	2	IPR002919
Domain	SAM_DOMAIN	KIF24 CASKIN1 TNKS2 BICC1	4.26e-03	95	129	4	PS50105
Domain	ZF_PHD_2	PHRF1 BPTF TRIM28 KDM2B	4.26e-03	95	129	4	PS50016
Domain	ZF_PHD_1	PHRF1 BPTF TRIM28 KDM2B	4.42e-03	96	129	4	PS01359
Domain	-	PKP4 ARMCX2 PPP4R4 RPTOR RIPOR1 HECTD1	4.46e-03	222	129	6	1.25.10.10
Domain	SAM	KIF24 CASKIN1 TNKS2 BICC1	4.59e-03	97	129	4	IPR001660
Domain	Prot-tyrosine_phosphatase-like	TNS2 DUSP15 DNAJC6 PTPRC	4.93e-03	99	129	4	IPR029021
Domain	-	KIF24 CASKIN1 TNKS2 BICC1	6.27e-03	106	129	4	1.10.150.50
Domain	PI3_PI4_kinase	PI4K2B PIK3C3	6.74e-03	18	129	2	PF00454
Domain	CTCK_1	MUC19 MUC5AC	6.74e-03	18	129	2	PS01185
Domain	PI3_4_KINASE_1	PI4K2B PIK3C3	6.74e-03	18	129	2	PS00915
Domain	PI3_4_KINASE_2	PI4K2B PIK3C3	6.74e-03	18	129	2	PS00916
Domain	PI3/4_kinase_cat_dom	PI4K2B PIK3C3	6.74e-03	18	129	2	IPR000403
Domain	PI3_4_KINASE_3	PI4K2B PIK3C3	6.74e-03	18	129	2	PS50290
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC12 MUC17 MUC4 MUC5AC MUC20	3.79e-10	16	88	6	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC12 MUC17 MUC4 MUC5AC MUC20	5.83e-10	17	88	6	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC19 MUC16 MUC17 MUC4 MUC5AC MUC20	2.51e-09	21	88	6	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC12 MUC17 MUC4 MUC5AC MUC20	4.61e-09	23	88	6	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC12 MUC17 MUC4 MUC5AC MUC20	1.04e-08	26	88	6	M27483
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC19 MUC16 MUC17 MUC4 MUC5AC MUC20	1.90e-06	60	88	6	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC12 MUC17 MUC4 MUC5AC MUC20	2.31e-06	62	88	6	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC12 MUC17 MUC4 MUC5AC MUC20	4.00e-06	68	88	6	M27303
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 MUC12 MUC17 MAP3K7 MUC4 MUC5AC MUC20	2.66e-05	140	88	7	M27484
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC16 MUC12 MUC17 ACAN MUC4 MUC5AC MUC20	3.05e-05	143	88	7	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC19 MUC16 MUC17 MUC4 MUC5AC MUC20	6.03e-05	109	88	6	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC12 MUC17 MUC4 MUC5AC MUC20	6.67e-05	111	88	6	M27416
Pathway	REACTOME_RHO_GTPASE_CYCLE	PLEKHG4 PKP4 ARHGAP39 GMIP TRIP10 ZNF512B PLEKHG6 RALBP1 AKAP13 DOCK6 CPSF7	1.08e-04	450	88	11	M27078
Pathway	WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING	IL10RA PTPRC TRIM28 RPTOR IL9R	1.25e-04	78	88	5	M39824
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC16 MUC12 MUC17 ACAN MTRR MUC4 MUC5AC MUC20	1.66e-04	250	88	8	M27554
Pathway	REACTOME_RHO_GTPASE_CYCLE	PKP4 ARHGAP39 GMIP TRIP10 ZNF512B PLEKHG6 RALBP1 AKAP13 DOCK6 CPSF7	3.99e-04	439	88	10	MM15595
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC12 MUC17 MUC4 MUC5AC MUC20	4.29e-13	18	139	7	18834073
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CAAP1 RALGAPB PHRF1 FNBP4 ARHGAP39 BLM PACS1 BPTF SCAF1 PTPRC GSE1 SLC4A1AP UBAP2L TRIM28 RPTOR KDM2B RIPOR1 TP53BP1	2.22e-09	774	139	18	15302935
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1B SPEG PER1 ITGB4 C6orf132 FANCA TBC1D16 SCAF1 ORAI1 CELSR1 AATK TRIM28 RPTOR CASKIN1 TXNRD3 EHMT1 AKAP13 RIPOR1 DOCK6 HECTD1 AGAP3	3.32e-09	1105	139	21	35748872
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4 MUC20	6.25e-08	3	139	3	30236127
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12 MUC20	6.25e-08	3	139	3	26770020
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DCAF6 KIF1A TBC1D5 RALGAPB FRMPD1 FNBP4 ARHGAP39 PPP4R4 SHISA9 PACS1 BPTF COL18A1 PIK3C3 UBAP2L RPTOR EHMT1 AKAP13 RIPOR1 TSC22D4 DOCK6 HECTD1 AGAP3	1.19e-07	1489	139	22	28611215
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAPK8IP1 HCN4 TBC1D5 PKP4 BCL11A SPECC1L ARHGAP39 DNAJC6 KHSRP CAMKV UBAP2L TRIM28 RPTOR CASKIN1 EHMT1 BSN TP53BP1	3.33e-07	963	139	17	28671696
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MAPK8IP1 HCN4 PER1 LRRC4B TACC2 ARHGAP39 KHSRP SHISA9 CAMKV UBAP2L TRIM28 ELFN1 RPTOR CASKIN1 BSN MAP3K7 TP53BP1 AGAP3	7.28e-07	1139	139	18	36417873
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	SETD1B TACC2 RAD54L2 BLM GTF2F1 SALL2 GSE1 RPTOR TONSL KDM2B BSN TP53BP1 CPSF7	7.54e-07	588	139	13	38580884
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TACC2 ITGB4 NUP35 KHSRP BLM GTF2F1 UBAP2L TRIM28 RPTOR AKAP13 TP53BP1 AGAP3	9.31e-07	503	139	12	16964243
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MAPK8IP1 PKP4 BCL11A SPECC1L ARHGAP39 DNAJC6 PDLIM5 KHSRP PACS1 CAMKV UBAP2L TRIM28 RPTOR CASKIN1 USP4 TSC22D4 BSN DMTN CPSF7 AGAP3	1.13e-06	1431	139	20	37142655
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5AC	1.24e-06	6	139	3	19110483
Pubmed	Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins.	SPN PTPRC CX3CL1	1.24e-06	6	139	3	21768350
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	SPECC1L RAD54L2 ARMCX2 KHSRP FANCA BLM SLC4A1AP TRIM28 TONSL TP53BP1 CPSF7	2.27e-06	453	139	11	29656893
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	PLEKHG4 ARHGAP36 PKP4 ARHGAP39 GMIP TRIP10 NUP35 PLEKHG6 UBAP2L RALBP1 AKAP13 TNKS2 DOCK6 MAP3K7 AGAP3	4.27e-06	916	139	15	32203420
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SETD1B KHSRP BPTF SCAF1 SLC4A1AP TRIM28 TP53BP1 CPSF7	8.21e-06	251	139	8	31076518
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CAAP1 KIF1A PKP4 RALGAPB PHRF1 SPECC1L ARHGAP39 NUP35 C6orf132 BLM SCAF1 COL18A1 ORAI1 GTF2F1 CELSR1 SLC4A1AP EHMT1 KDM2B AGAP3	8.57e-06	1497	139	19	31527615
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MAGEL2 TBC1D5 RAD54L2 MAGEE1 C6orf132 AATK TONSL SCN10A AKAP13 BSN	9.71e-06	430	139	10	35044719
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TBC1D5 RALGAPB PPP4R4 C6orf132 PIK3C3 RPTOR AKAP13 NR3C2 TSC22D4 DOCK6 HECTD1 BICC1 DMTN AGAP3	9.83e-06	861	139	14	36931259
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	1.07e-05	72	139	5	10380929
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	PKP4 ARHGAP39 DNAJC6 UBAP2L RPTOR CASKIN1 BSN MAP3K7 DMTN	1.16e-05	347	139	9	17114649
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	1.49e-05	77	139	5	10835267
Pubmed	USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling.	USP4 MAP3K7	1.59e-05	2	139	2	30622220
Pubmed	MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.	MUC4 MUC5AC	1.59e-05	2	139	2	18475301
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	1.59e-05	2	139	2	22220206
Pubmed	Hypertrophy in skeletal myotubes induced by junctophilin-2 mutant, Y141H, involves an increase in store-operated Ca2+ entry via Orai1.	JPH2 ORAI1	1.59e-05	2	139	2	22389502
Pubmed	Cytokine receptor clustering in sensory neurons with an engineered cytokine fusion protein triggers unique pain resolution pathways.	IL10RA SCN10A	1.59e-05	2	139	2	33836560
Pubmed	Eosinophilic allergic rhinitis is strongly associated with the CD45RBlo subset of CD161+ Th2 cells that secretes IL-2, IL-3, IL-4, IL-5, IL-9, and IL-13.	PTPRC KLRB1	1.59e-05	2	139	2	37551093
Pubmed	Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome.	PER1 PER3	1.59e-05	2	139	2	11306557
Pubmed	Nuclear import of mPER3 in Xenopus oocytes and HeLa cells requires complex formation with mPER1.	PER1 PER3	1.59e-05	2	139	2	16008569
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	1.59e-05	2	139	2	23544943
Pubmed	USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1.	USP4 MAP3K7	1.59e-05	2	139	2	37949874
Pubmed	Role of O-glycosylation and expression of CD43 and CD45 on the surfaces of effector T cells in human T cell leukemia virus type 1 cell-to-cell infection.	SPN PTPRC	1.59e-05	2	139	2	22171268
Pubmed	Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice.	MUC4 MUC5AC	1.59e-05	2	139	2	19158956
Pubmed	Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.	MUC16 MUC5AC	1.59e-05	2	139	2	24722639
Pubmed	PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells.	PER1 PER3	1.59e-05	2	139	2	21459569
Pubmed	Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.	MUC16 MUC5AC	1.59e-05	2	139	2	18782111
Pubmed	An atypical 12q24.31 microdeletion implicates six genes including a histone demethylase KDM2B and a histone methyltransferase SETD1B in syndromic intellectual disability.	SETD1B KDM2B	1.59e-05	2	139	2	27106595
Pubmed	Polymorphisms in period genes and bone response to hormone therapy in postmenopausal Korean women.	PER1 PER3	1.59e-05	2	139	2	26624862
Pubmed	Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.	MUC4 MUC20	1.59e-05	2	139	2	26673820
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHA9 PCDHGA7 PCDHGA6 CELSR1 PCDHGA8	1.79e-05	80	139	5	10716726
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	KIF1A PKP4 ARHGAP39 NUP35 PACS1 BSN MAP3K7	2.92e-05	218	139	7	33378226
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	PLEKHG4 TBC1D5 TNS2 RAD54L2 MAGEE1 ITGB4 PDLIM5 SCAF1 UBAP2L TSC22D4 CPSF7	3.54e-05	608	139	11	16713569
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1B SPEG RALGAPB FRMPD1 BCL11A DNAJC6 GSE1 UBAP2L RIPOR1	4.05e-05	407	139	9	12693553
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CAAP1 DCAF6 PKP4 PHRF1 PER1 BCL11A ZNF512B BPTF SCAF1 SALL2 GSE1 TRIM28 RPTOR EHMT1 AGAP3	4.29e-05	1116	139	15	31753913
Pubmed	Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.	MUC16 MUC5AC	4.75e-05	3	139	2	33232357
Pubmed	Expression profiles of PERIOD1, 2, and 3 in peripheral blood mononuclear cells from older subjects.	PER1 PER3	4.75e-05	3	139	2	19013183
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	4.75e-05	3	139	2	23053434
Pubmed	TRIM28/TIF1β and Fli-1 negatively regulate peroxynitrite generation via DUOX2 to decrease the shedding of membrane-bound fractalkine in human macrophages after exposure to substance P.	TRIM28 CX3CL1	4.75e-05	3	139	2	32673994
Pubmed	A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light.	PER1 PER3	4.75e-05	3	139	2	9428527
Pubmed	DNA repair and cell cycle checkpoint defects in a mouse model of 'BRCAness' are partially rescued by 53BP1 deletion.	BLM TP53BP1	4.75e-05	3	139	2	29620483
Pubmed	Low-Salt Diet and Circadian Dysfunction Synergize to Induce Angiotensin II-Dependent Hypertension in Mice.	PER1 PER3	4.75e-05	3	139	2	26781276
Pubmed	Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei.	PER1 PER3	4.75e-05	3	139	2	9427249
Pubmed	Association between polymorphisms in period genes and bone density in postmenopausal Korean women.	PER1 PER3	4.75e-05	3	139	2	24678593
Pubmed	Photic entrainment of period mutant mice is predicted from their phase response curves.	PER1 PER3	4.75e-05	3	139	2	20826680
Pubmed	mPeriod2 Brdm1 and other single Period mutant mice have normal food anticipatory activity.	PER1 PER3	4.75e-05	3	139	2	29138421
Pubmed	A time memory engram embedded in a light-entrainable circadian clock.	PER1 PER3	4.75e-05	3	139	2	37951213
Pubmed	Influence of age on clock gene expression in peripheral blood cells of healthy women.	PER1 PER3	4.75e-05	3	139	2	19861640
Pubmed	KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair.	TRIM28 TP53BP1	4.75e-05	3	139	2	25905708
Pubmed	Unwinding the differences of the mammalian PERIOD clock proteins from crystal structure to cellular function.	PER1 PER3	4.75e-05	3	139	2	22331899
Pubmed	Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes.	PER1 PER3	4.75e-05	3	139	2	15031135
Pubmed	Period determination in the food-entrainable and methamphetamine-sensitive circadian oscillator(s).	PER1 PER3	4.75e-05	3	139	2	22891330
Pubmed	Period Family of Clock Genes as Novel Predictors of Survival in Human Cancer: A Systematic Review and Meta-Analysis.	PER1 PER3	4.75e-05	3	139	2	32849922
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC4	4.75e-05	3	139	2	27483328
Pubmed	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	MUC16 MUC4	4.75e-05	3	139	2	24204560
Pubmed	BLM helicase-dependent and -independent roles of 53BP1 during replication stress-mediated homologous recombination.	BLM TP53BP1	4.75e-05	3	139	2	17591918
Pubmed	Circadian clock regulates hepatic polyploidy by modulating Mkp1-Erk1/2 signaling pathway.	PER1 PER3	4.75e-05	3	139	2	29269828
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	4.75e-05	3	139	2	24939955
Pubmed	The complex relationship between the light-entrainable and methamphetamine-sensitive circadian oscillators: evidence from behavioral studies of Period-mutant mice.	PER1 PER3	4.75e-05	3	139	2	23869717
Pubmed	Association Between Interleukin-10 Receptors and the CD45-Immunophenotype of Central Nervous System Tumors: A Preliminary Study.	IL10RA PTPRC	4.75e-05	3	139	2	28982901
Pubmed	Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene.	BLM ACAN	4.75e-05	3	139	2	9808625
Pubmed	Upregulation of KSRP by miR-27b provides IFN-γ-induced post-transcriptional regulation of CX3CL1 in liver epithelial cells.	KHSRP CX3CL1	4.75e-05	3	139	2	26631623
Pubmed	Expression of mucin (MUC) genes in mucoepidermoid carcinoma.	MUC19 MUC4	4.75e-05	3	139	2	21072847
Pubmed	Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection.	PER1 PER3	4.75e-05	3	139	2	25344870
Pubmed	Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock.	PER1 PER3	4.75e-05	3	139	2	11395012
Pubmed	Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity.	PER1 PER3	4.75e-05	3	139	2	12032351
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC4	4.75e-05	3	139	2	17592322
Pubmed	Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.	PER1 PER3	4.75e-05	3	139	2	15790588
Pubmed	Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer.	PER1 PER3	4.75e-05	3	139	2	25550826
Pubmed	Two atypical enteropathogenic Escherichia coli strains induce the production of secreted and membrane-bound mucins to benefit their own growth at the apical surface of human mucin-secreting intestinal HT29-MTX cells.	MUC17 MUC4	4.75e-05	3	139	2	20065027
Pubmed	A flexible summary statistics-based colocalization method with application to the mucin cystic fibrosis lung disease modifier locus.	MUC4 MUC20	4.75e-05	3	139	2	35065708
Pubmed	A light-independent oscillatory gene mPer3 in mouse SCN and OVLT.	PER1 PER3	4.75e-05	3	139	2	9707434
Pubmed	Intracellular calcium mobilization induces period genes via MAP kinase pathways in NIH3T3 cells.	PER1 PER3	4.75e-05	3	139	2	11959112
Pubmed	Comparing expression levels of PERIOD genes PER1, PER2 and PER3 in chronic insomnia patients and medical staff working in the night shift.	PER1 PER3	4.75e-05	3	139	2	32805476
Pubmed	Nuclear export of mammalian PERIOD proteins.	PER1 PER3	4.75e-05	3	139	2	11591712
Pubmed	γ-H2AX/53BP1/pKAP-1 foci and their linear tracks induced by in vitro exposure to radon and its progeny in human peripheral blood lymphocytes.	TRIM28 TP53BP1	4.75e-05	3	139	2	27922110
Pubmed	The role of phosphorylation and degradation of hPER protein oscillation in normal human fibroblasts.	PER1 PER3	4.75e-05	3	139	2	14712925
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC4	4.75e-05	3	139	2	35879412
Pubmed	The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses.	SPN PTPRC	4.75e-05	3	139	2	12626536
Pubmed	Clinicopathological and prognostic significance of MUC-2, MUC-4 and MUC-5AC expression in japanese gastric carcinomas.	MUC4 MUC5AC	4.75e-05	3	139	2	23464473
Pubmed	Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells.	SPN ITGB4 PTPRC KLRB1	6.15e-05	53	139	4	1431091
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	TBC1D5 PKP4 RALGAPB GMIP RAD54L2 FANCA PACS1 GTF2F1 GSE1 TONSL AKAP13	6.44e-05	650	139	11	38777146
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SETD1B FNBP4 TRIP10 NUP35 BLM UBAP2L TRIM28 HECTD1 TP53BP1	7.36e-05	440	139	9	34244565
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	FNBP4 SPECC1L PDLIM5 KHSRP BPTF UBAP2L TRIM28 NFKBIE KDM2B TP53BP1	7.66e-05	549	139	10	38280479
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TBC1D5 TACC2 RAD54L2 BLM SALL2 SLC4A1AP UBAP2L TRIM28 MTRR	7.89e-05	444	139	9	34795231
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TBC1D5 PKP4 RALGAPB TNS2 ARHGAP39 PPP4R4 ZNF512B BLM PACS1 GTF2F1 PTPRC GSE1 SLC4A1AP MAP3K7	8.42e-05	1049	139	14	27880917
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	PKP4 RAD54L2 NUP35 KHSRP GSE1 CPSF7	8.98e-05	180	139	6	35198878
Pubmed	An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome.	PER1 PER3	9.47e-05	4	139	2	11232563
Pubmed	BLM helicase regulates DNA repair by counteracting RAD51 loading at DNA double-strand break sites.	BLM TP53BP1	9.47e-05	4	139	2	28912125
Pubmed	Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.	PTPRC IL9R	9.47e-05	4	139	2	25421756
Interaction	SIN3A interactions	PER1 BCL11A MAGEE1 PDLIM5 KHSRP ZNF512B BPTF GSE1 TRIM28 CHFR KDM2B KDF1 HECTD1 TP53BP1	3.00e-07	380	136	14	int:SIN3A
Interaction	YWHAH interactions	SPEG TBC1D5 RALGAPB TNS2 SPECC1L PPP4R4 C6orf132 PACS1 SHROOM1 PIK3C3 RPTOR AKAP13 USP4 NR3C2 TSC22D4 DOCK6 MAP3K7 HECTD1 BICC1 DMTN MAST3 AGAP3	4.53e-06	1102	136	22	int:YWHAH
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHA9 PCDHGA7 PCDHGA6 SHROOM1 PROB1 PCDHGA8	3.10e-04	298	139	6	chr5q31
Cytoband	5q31	PCDHA9 PCDHGA7 PCDHGA6 PCDHGA8	4.29e-04	115	139	4	5q31
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC12 MUC17 MUC4 MUC5AC MUC20	1.30e-11	21	99	7	648
GeneFamily	Ankyrin repeat domain containing	ANKRD13B CASKIN1 NFKBIE TONSL EHMT1 TNKS2 HECTD1 AGAP3	5.51e-05	242	99	8	403
GeneFamily	Clustered protocadherins	PCDHA9 PCDHGA7 PCDHGA6 PCDHGA8	4.18e-04	64	99	4	20
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	TNS2 DNAJC6	8.13e-04	8	99	2	837
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	KIF1A PLEKHG4 PLEKHG6 OSBPL7 AKAP13 AGAP3	9.46e-04	206	99	6	682
GeneFamily	Sterile alpha motif domain containing	KIF24 CASKIN1 TNKS2 BICC1	1.39e-03	88	99	4	760
GeneFamily	PHD finger proteins	PHRF1 BPTF TRIM28 KDM2B	1.51e-03	90	99	4	88
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP36 ARHGAP39 GMIP	2.59e-03	50	99	3	721
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	PI4K2B TRIP10 AKAP13	2.74e-03	51	99	3	870
Coexpression	NABA_ECM_AFFILIATED	MUC19 MUC16 MUC12 MUC17 ELFN1 MUC4 MUC5AC MUC20	3.26e-06	170	137	8	M5880
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	PKP4 RALGAPB PDLIM5 PACS1 UBAP2L TRIM28 MTRR RSRP1 AKAP13 USP4 TP53BP1	8.45e-06	399	137	11	M41172
Coexpression	GSE13306_TREG_RA_VS_TCONV_RA_DN	KIF1A JPH2 ARHGAP39 RAD54L2 ASTL COL18A1 DOCK6 IL9R	1.08e-05	200	137	8	M3227
Coexpression	NABA_ECM_AFFILIATED	MUC19 MUC16 MUC17 ELFN1 MUC4 MUC5AC MUC20	2.02e-05	158	137	7	MM17063
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	ANKRD13B SPEG MUC19 APLP1 BCL11A DNAJC6 AATK GSE1 CASKIN1 BSN DMTN	3.47e-05	465	137	11	M39066
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANKRD13B KIF1A PCDHGA7 SHC4 DUSP15 SHROOM1 AATK TSC22D4	8.89e-08	177	139	8	59cf56c385c324f0844f20003d2b5049a2791e45
ToppCell	Neuronal_cells-Schwann_cells\|World / Lineage and Cell class	MAPK8IP1 KIF1A APLP1 LRRC4B DUSP15 ITGB4 SHROOM1 AATK	1.47e-07	189	139	8	371cdc92549269e45c23c5a5b3cae9c5d35ee217
ToppCell	Neuronal_cells\|World / Lineage and Cell class	MAPK8IP1 KIF1A APLP1 LRRC4B DUSP15 ITGB4 SHROOM1 AATK	1.47e-07	189	139	8	3948775a0ebd4b32c1623d5487f5581e6e2934d7
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 ITGB4 C6orf132 SLC7A2 CELSR1 HECTD1 MUC4 MUC20	2.27e-07	200	139	8	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Club_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	KIF1A SHC4 CELSR1 BSN CX3CL1 MUC4 PCDHGA8	8.57e-07	164	139	7	4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MUC19 C6orf132 PTPRC MUC17 ALPK2	2.70e-06	70	139	5	2121ba6a0beb2a8fdc589ff1063e7d8c2c3c68f6
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MUC19 C6orf132 PTPRC MUC17 ALPK2	2.70e-06	70	139	5	cd6bca68fe52f451716fc8c0b1745984bc9ec057
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MUC19 C6orf132 PTPRC MUC17 ALPK2	2.70e-06	70	139	5	be300c0447735aba89df4c3082b81eb5abf22770
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IL10RA SPN BLM PTPRC PROB1 KLRB1 IL9R	2.72e-06	195	139	7	c75d04b15d9f95fe2b5650cd4a5a376776610000
ToppCell	Tracheal-10x5prime-Stromal-Schwann-Schwann_Myelinating\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MAPK8IP1 KIF1A SHC4 APLP1 DUSP15 ARHGAP39 AATK	3.10e-06	199	139	7	2b567b6fd8addf059bbf2b72c55a7647aefdc595
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ITGB4 C6orf132 SLC7A2 CELSR1 HECTD1 MUC4 MUC20	3.21e-06	200	139	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DCAF6 SPEG C6orf132 TBC1D16 ZBTB37 TMUB2	7.74e-06	150	139	6	b6f1fc62d08199fed6156c7cd32f66d9926531b5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ODAD1 SPEG JPH2 LRRC4B SLC7A2 ACAN	8.35e-06	152	139	6	bd1f36b436d8ab7dd8420f595b97d851eab31a38
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ODAD1 SPEG JPH2 LRRC4B SLC7A2 ACAN	8.35e-06	152	139	6	ee329249a034a969a16b26a224aa04249d67382d
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	FRMPD1 SHC4 ZNF512B OSBPL7 KLRB1 DMTN	1.08e-05	159	139	6	2233fee5dcdb6c7dee5b1bd8efbc07d86b339927
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL10RA SPN TG FANCA PTPRC ALPK2	1.12e-05	160	139	6	94e4f5fc2156dd8163811c3b8b0781ea9b3f2e06
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL11A SPECC1L RAD54L2 FANCA GSE1 RPUSD2	1.53e-05	169	139	6	4e1322cc5e1733e9fb19e08f739a30206f43cea8
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5\|TCGA-Bladder / Sample_Type by Project: Shred V9	MAPK8IP1 KIF1A HCN4 FRMPD1 CAMKV BSN	1.53e-05	169	139	6	9c4e83fe8225d16173a103bf5a57b17d623be923
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MUC16 ITGB4 SHISA9 PLEKHG6 MUC4 MUC20	1.74e-05	173	139	6	d1e47c87bd4750801f3531f66a56c5dccb4ea64c
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHC4 MUC16 SHISA9 CX3CL1 MUC4 MUC5AC	1.74e-05	173	139	6	464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HCN4 PKP4 FANCA SCAF1 BSN MUC4	1.80e-05	174	139	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHC4 DNAJC6 COL18A1 AATK TONSL NR3C2	2.05e-05	178	139	6	3e8aacb27ed1a3c3978e21dddddd0828f8000692
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 ITGB4 MUC17 MUC4 MUC5AC MUC20	2.11e-05	179	139	6	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 ITGB4 MUC17 MUC4 MUC5AC MUC20	2.18e-05	180	139	6	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 ITGB4 MUC17 MUC4 MUC5AC MUC20	2.18e-05	180	139	6	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	Pericytes-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	SPEG JPH2 LRRC4B COL18A1 ACAN SOHLH1	2.32e-05	182	139	6	46c213597445b1f4f09dc367f27702d24b201daf
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 SHISA9 CELSR1 CX3CL1 MUC4 MUC5AC	2.32e-05	182	139	6	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A SHC4 DUSP15 ARHGAP39 AATK TSC22D4	2.54e-05	185	139	6	11c147f3f5570c4761d2bcff3bad28146b4a5861
ToppCell	(00)_Basal-(4)_1wkpi\|(00)_Basal / shred by cell type and Timepoint	PER1 TNS2 ITGB4 PER3 RSRP1 CX3CL1	2.54e-05	185	139	6	bf82ba905e5eee1c39a2731702071d3de10a78b8
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PER1 PTPRC RSRP1 AKAP13 HECTD1 KLRB1	2.70e-05	187	139	6	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A SHC4 DUSP15 PPP4R4 AATK TSC22D4	2.78e-05	188	139	6	c2101ded71fb16b8ddbc1f883911b1ed2a533ffc
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A SHC4 DUSP15 PPP4R4 AATK TSC22D4	2.78e-05	188	139	6	3b8b9161f0fdcbde302ce5b4c0bc874628211109
ToppCell	droplet-Heart-HEART-1m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHC4 LRRC4B ARHGAP39 ITGB4 COL18A1 AATK	2.78e-05	188	139	6	921a2c9212a0f2a00fd72c594d80924f27e8b9b7
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A PKP4 APLP1 PER3 GSE1 AKAP13	2.78e-05	188	139	6	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ODAD1 MUC16 TACC2 C6orf132 SLC7A2 MUC4	3.04e-05	191	139	6	9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4
ToppCell	droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD1 PER1 ITGB4 KIF24 COL18A1 DOCK6	3.04e-05	191	139	6	4bfdf44d4402a42530d30c89d94946acdda4321b
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ODAD1 MUC16 TACC2 C6orf132 SLC7A2 MUC4	3.04e-05	191	139	6	df8a1a6e78aa0cb941b94cb676bd6891d79f3687
ToppCell	Control-Epithelial\|Control / Disease group,lineage and cell class （2021.01.30）	ODAD1 MUC16 TACC2 C6orf132 SLC7A2 MUC4	3.04e-05	191	139	6	b78547dae8328244a47c83346447bdd787efbcae
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TMPRSS13 KIF1A MUC16 APLP1 PLEKHG6 MUC20	3.32e-05	194	139	6	d024cd75a97f048257e49cee9190fb2e79202ee2
ToppCell	Fibroblasts-Pericytes\|Fibroblasts / lung cells shred on cell class, cell subclass, sample id	SPEG JPH2 LRRC4B PDLIM5 COL18A1 ACAN	3.42e-05	195	139	6	c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1
ToppCell	Tracheal-10x5prime-Stromal-Schwann\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KIF1A ARHGAP36 SHC4 ARHGAP39 SHISA9 AATK	3.52e-05	196	139	6	b6226163d9fc93ecfff2115bb74408303a000490
ToppCell	facs-Brain_Non-Myeloid-Cortex\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPK8IP1 KIF1A APLP1 AATK TSC22D4 MAST3	3.52e-05	196	139	6	256fe9bc0815f66a9afe11ba3507ef1372b52fd3
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ODAD1 MUC16 TACC2 SLC7A2 MUC4 MUC20	3.83e-05	199	139	6	1ee4010d8557564e25e8ee00b914c2dfd9037838
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ODAD1 MUC16 TACC2 SLC7A2 MUC4 MUC20	3.83e-05	199	139	6	1df69c0cb5f759f6a2152521842506a75bb95cae
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 ITGB4 C6orf132 MUC4 MUC5AC MUC20	3.83e-05	199	139	6	d04062d86643e5712cc2f519f4f36e643d404a16
ToppCell	Mild-Epithelial-Epithelial-\|Mild / Condition, Lineage, Cell class and cell subclass	ODAD1 MUC16 TACC2 SLC7A2 MUC4 MUC20	3.83e-05	199	139	6	81115bbd2c10bfdd38376d2075f03a59c31870d2
ToppCell	NS-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 TACC2 C6orf132 MUC4 MUC5AC MUC20	3.83e-05	199	139	6	d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ODAD1 MUC16 TACC2 SLC7A2 MUC4 MUC20	3.83e-05	199	139	6	74087b4b5e567310fc4ac58fb267ff651a180680
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SPEG JPH2 LRRC4B COL18A1 SLC7A2 ACAN	3.83e-05	199	139	6	ad75e5e26c37a97331164d7f77235ebd9a933a44
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ODAD1 MUC16 TACC2 SLC7A2 MUC4 MUC20	3.83e-05	199	139	6	00b5ce099c50a5e1786ce2b3a06ee0931a8205a4
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PCDHA9 ITGB4 SALL2 ACAN CASKIN1 BICC1	3.83e-05	199	139	6	45c3b853900d8c3d5965117d904e3714100138bc
ToppCell	Mild-Epithelial\|Mild / Condition, Lineage, Cell class and cell subclass	ODAD1 MUC16 TACC2 SLC7A2 MUC4 MUC20	3.83e-05	199	139	6	ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18
ToppCell	Mild-Epithelial-Epithelial\|Mild / Condition, Lineage, Cell class and cell subclass	ODAD1 MUC16 TACC2 SLC7A2 MUC4 MUC20	3.83e-05	199	139	6	91308b255783ad4029e5575028c18d7550832c51
ToppCell	Mild_COVID-19-Epithelial\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ODAD1 MUC16 TACC2 SLC7A2 MUC4 MUC20	3.83e-05	199	139	6	72689bda7476930887ae007682fcab27f956f050
ToppCell	Severe_COVID-19-Epithelial-Basal/Club\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MUC16 ITGB4 C6orf132 MUC4 MUC5AC MUC20	3.83e-05	199	139	6	2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 ITGB4 C6orf132 MUC4 MUC5AC MUC20	3.83e-05	199	139	6	fd364f43859b2e7a3e91ce6a1c430cc42ad26a49
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPK8IP1 APLP1 ITGB4 AATK TSC22D4 MAST3	3.93e-05	200	139	6	0e85c90719d9ec51a566e230c9dd2909d8df1f52
ToppCell	Bronchial-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 TACC2 C6orf132 CELSR1 MUC4 MUC20	3.93e-05	200	139	6	d3ee5f79513e2ac02ad3329b59e6290d457c44d2
ToppCell	NS-control-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 TACC2 ITGB4 C6orf132 MUC4 MUC20	3.93e-05	200	139	6	d014959891893b6d3854a471fba1dc50c6625a0a
ToppCell	Severe-Epithelial-Epithelial-\|Severe / Condition, Lineage, Cell class and cell subclass	MUC16 TACC2 ITGB4 C6orf132 MUC4 MUC20	3.93e-05	200	139	6	8669ce08f93eefb8ac970e30cdc4b1f908023c54
ToppCell	Severe-Epithelial\|Severe / Condition, Lineage, Cell class and cell subclass	MUC16 TACC2 ITGB4 C6orf132 MUC4 MUC20	3.93e-05	200	139	6	6ead9db88568bb829d564a6d8e85f71fd765bac0
ToppCell	BAL-Severe-Epithelial\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ODAD1 MUC16 TACC2 C6orf132 MUC4 MUC20	3.93e-05	200	139	6	0cc7ff7b6a4eb05d2370ec2f3b9dbfe8cb0699de
ToppCell	BAL-Severe-Epithelial-Epithelial\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ODAD1 MUC16 TACC2 C6orf132 MUC4 MUC20	3.93e-05	200	139	6	b9cede2e0939c6b60ce1aa16d7efaaae79354580
ToppCell	BAL-Severe-Epithelial\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ODAD1 MUC16 TACC2 C6orf132 MUC4 MUC20	3.93e-05	200	139	6	b762bf6f432eac05a476f6e2ab4da27dd13a2317
ToppCell	BAL-Severe-Epithelial-Epithelial\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ODAD1 MUC16 TACC2 C6orf132 MUC4 MUC20	3.93e-05	200	139	6	4c63204e0d868dd4c11c1604a238624a3ad54485
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIF1A SHC4 APLP1 SHISA9 COL18A1 CAMKV	3.93e-05	200	139	6	553e9612874480f4d2a45671462e266cd0a09321
ToppCell	Severe_COVID-19-Epithelial\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ODAD1 MUC16 TACC2 C6orf132 MUC4 MUC20	3.93e-05	200	139	6	49910efb6d888c208cd50530b03af19f87070630
ToppCell	Severe-Epithelial-Epithelial\|Severe / Condition, Lineage, Cell class and cell subclass	MUC16 TACC2 ITGB4 C6orf132 MUC4 MUC20	3.93e-05	200	139	6	3bd1ce2793651c9badd69f011d2531183594e5f4
ToppCell	COVID-19_Moderate-B_cell\|COVID-19_Moderate / disease group, cell group and cell class	PCDHGA7 DNAJC6 COL18A1 SALL2 PER3	8.36e-05	142	139	5	88bb8d9bca66131df4ee7021b88248e146aa7aa6
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TMPRSS13 FRMPD1 MUC19 ACAN	8.49e-05	74	139	4	06760e7179980685beddaaf7b14f4f9f932fe79c
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma-2\|TCGA-Pancreas / Sample_Type by Project: Shred V9	LRRC4B DUSP15 PPP4R4 CASKIN1 BSN	9.53e-05	146	139	5	bc2adef529d0bbfcccef7435401a47a6ffcc1832
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma\|TCGA-Pancreas / Sample_Type by Project: Shred V9	LRRC4B DUSP15 PPP4R4 CASKIN1 BSN	9.53e-05	146	139	5	72c1e7e0c2b6ff6c4084af61fa19c2b8eab16eda
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SHC4 ARHGAP39 MAGEE1 TXNRD3 MUC4	1.02e-04	148	139	5	e7bbb5ddf44b11b8495e83863fbf1fd9f3f24472
ToppCell	pdx-Tumor_cells-T4\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MUC16 GMIP TMEM70 FBXO43 MUC4	1.15e-04	152	139	5	7ccc56b79c499dd48dab8e2d936edca5223b9356
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_large-bowel / Manually curated celltypes from each tissue	PLEKHG4 COL18A1 PTPRC PLEKHG6 RSRP1	1.15e-04	152	139	5	95944864ce7539ff8de028f5700694931338f3ff
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FNBP4 SALL2 PTPRC ELFN1 CASKIN1	1.19e-04	153	139	5	64d0f37d7af9b76234f683379e3689771f71fe70
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPN BLM PTPRC BSN ALPK2	1.38e-04	158	139	5	5d926be5a0ebe8257cd552afa7844171f9ff01c0
ToppCell	facs-Heart-RV-24m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP4R4 ELFN1 SCN10A MUC5AC PCDHGA8	1.46e-04	160	139	5	41d6c811c445c0ba9b6a2deb10a3b6b793172582
ToppCell	facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP4R4 ELFN1 SCN10A MUC5AC PCDHGA8	1.46e-04	160	139	5	c1d03c0ac9c12615a06499209fcdf18e9b6f1fba
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 SHISA9 CELSR1 MUC4 MUC20	1.51e-04	161	139	5	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	SPEG FNBP4 PTPRC RSRP1 NR3C2	1.55e-04	162	139	5	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	Bronchial-10x5prime-Stromal-Schwann\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MAPK8IP1 KIF1A DUSP15 COL18A1 AATK	1.55e-04	162	139	5	afffecc6c504930554aafc12c5bffa53e3c5b016
ToppCell	Adult-Epithelial-lung_goblet_cell-D175\|Adult / Lineage, Cell type, age group and donor	SHC4 MUC16 SHISA9 MUC4 MUC5AC	1.64e-04	164	139	5	6e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	DCAF6 SETD1B TBC1D5 UBAP2L IMPG2	1.74e-04	166	139	5	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	LA-16._Neuronal\|LA / Chamber and Cluster_Paper	SHC4 DNAJC6 ITGB4 SHISA9 AATK	1.84e-04	168	139	5	c55bbfbde8bb954f1cb9af82007bdd1f8070fee3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IL10RA LRRC4B AATK PTPRC KLRB1	1.94e-04	170	139	5	28fb192b21cdc5a77ba4f276694cff852eb2304b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IL10RA LRRC4B AATK PTPRC KLRB1	1.94e-04	170	139	5	239cb4b801b2d71a6facb386f2684c0851504151
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGB4 C6orf132 SHROOM1 PLEKHG6 MUC5AC	1.99e-04	171	139	5	59b9dbaa05b6e5740edc633c9ce1181565550d5b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGB4 C6orf132 SHROOM1 PLEKHG6 MUC5AC	1.99e-04	171	139	5	a5b9dd2b6a54db7962beeb5a9ceb9dacfb613fa7
ToppCell	Int-URO-Lymphocyte-T_NK-dnT\|Int-URO / Disease, Lineage and Cell Type	PI4K2B MUC12 RPTOR OSBPL7 RPUSD2	2.05e-04	172	139	5	e70299573da1679d6d286c3a43699cbff76e207d
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	SHC4 ARHGAP39 DNAJC6 ITGB4 SHISA9	2.10e-04	173	139	5	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	wk_20-22-Epithelial-PNS\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SHC4 SHISA9 COL18A1 AATK TSC22D4	2.10e-04	173	139	5	17b1a6b0318925d5d920f2c0a791745b9587ebef
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS13 CELSR1 PLEKHG6 OSBPL7 IL9R	2.16e-04	174	139	5	1c073177c1753e3b91ef8fd9e95230a1d13c82f3
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-5\|TCGA-Pancreas / Sample_Type by Project: Shred V9	MUC16 ITGB4 FANCA CELSR1 MUC4	2.16e-04	174	139	5	73e1ad4007d94fca25ed7c6fbe5d205d4e1b8a3b
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS13 CELSR1 PLEKHG6 OSBPL7 IL9R	2.16e-04	174	139	5	5491ad5c144baf2ef9b1c58eb720c872d14feb15
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 C6orf132 PLEKHG6 MUC4 MUC5AC	2.22e-04	175	139	5	8252ddc2ca95071381f0354aefb70c4714828491
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 C6orf132 PLEKHG6 MUC4 MUC5AC	2.22e-04	175	139	5	8ccf60fc469059d7aaf4e6ce54159db2962e0060
ToppCell	wk_20-22-Epithelial-PNS-Late_Schwann\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SHC4 SHISA9 COL18A1 AATK TSC22D4	2.28e-04	176	139	5	81924471d8a8c5bd8eedf294c007e25b6cd3e417
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MUC16 ITGB4 CELSR1 MUC4 MUC20	2.28e-04	176	139	5	8d9d0fb46c418b2067be58aec822e8c2b1561461
ToppCell	ASK428-Epithelial-Secretory\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	ITGB4 TG PTPRC EHMT1 MUC4	2.34e-04	177	139	5	66074a288501c136b4e83b883db5f0d8269ee326
Drug	PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A	SPN TBC1D5 TNS2 ARMCX2 PPP4R4 CREBZF PACS1 OSBPL7 TSC22D4 DOCK6	3.63e-07	199	137	10	6410_UP
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; PC3; HT_HG-U133A	PCDHA9 KIF1A PER1 RAD54L2 CREBZF AATK RIPOR1 TSC22D4 DMTN	2.87e-06	195	137	9	4495_DN
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A	SPN GMIP ITGB4 FANCA GTF2F1 AKAP13 DOCK6 TMUB2 CPSF7	3.00e-06	196	137	9	1794_DN
Drug	Sulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HG-U133A	PDLIM5 FANCA ZNF512B AATK SALL2 GSE1 MTRR DMTN CCDC93	3.26e-06	198	137	9	1913_DN
Drug	Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	KIF1A SPN FRMPD1 TNS2 ITGB4 COL18A1 PLEKHG6 CPSF7	2.27e-05	193	137	8	4241_DN
Drug	Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HG-U133A	PKP4 PER1 APLP1 FANCA ACAN MTRR TNKS2 MAP3K7	2.44e-05	195	137	8	1960_UP
Drug	Trioxsalen [3902-71-4]; Down 200; 17.6uM; PC3; HT_HG-U133A	SPN APLP1 GSE1 UBAP2L AKAP13 RIPOR1 DOCK6 DMTN	2.44e-05	195	137	8	5736_DN
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A	PCDHA9 SPN TG ACAN SCN10A DOCK6 MUC4 CCDC93	2.53e-05	196	137	8	6464_UP
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	KIF1A RAD54L2 PACS1 SALL2 AKAP13 RIPOR1 MAST3 CCDC93	2.63e-05	197	137	8	6930_DN
Drug	SC-58125; Up 200; 10uM; MCF7; HG-U133A	SPN SPEG FRMPD1 ACAN ZNF358 TMEM70 RIPOR1 CX3CL1	2.82e-05	199	137	8	254_UP
Drug	Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A	SPN TBC1D5 TNS2 APLP1 COL18A1 CELSR1 AKAP13 DOCK6	2.82e-05	199	137	8	7365_DN
Drug	DNA-PK Inhibitor III; Up 200; 1uM; PC3; HT_HG-U133A	SPN BCL11A ITGB4 PDLIM5 KHSRP PLEKHG6 DMTN CCDC93	2.93e-05	200	137	8	7518_UP
Drug	Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A	TBC1D5 PER1 BCL11A RAD54L2 RIPOR1 DOCK6 KLRB1 DMTN	2.93e-05	200	137	8	7463_UP
Drug	cellobiitol	SPN MUC12 MUC4 MUC5AC	7.10e-05	37	137	4	CID000003871
Drug	Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A	KIF1A SPN TBC1D5 ITGB4 PDLIM5 EHMT1 DMTN	1.08e-04	179	137	7	3388_DN
Drug	18-hydroxycorticosterone	CREBZF TXNRD3 MTRR NR3C2	1.18e-04	42	137	4	CID000011222
Drug	bromfenacoum	PKP4 DNAJC6 PDLIM5 SCAF1 GTF2F1 UBAP2L RALBP1 CASKIN1 MTRR USP4 BSN HECTD1 CPSF7	1.42e-04	644	137	13	ctd:C013418
Drug	Domperidone maleate; Up 200; 7.4uM; PC3; HT_HG-U133A	SPEG DNAJC6 PDLIM5 KHSRP ZNF358 BICC1 DMTN	1.61e-04	191	137	7	4640_UP
Drug	GSK-3beta Inhibitor VIII; Down 200; 10uM; PC3; HT_HG-U133A	SPN TBC1D5 BCL11A PDLIM5 CREBZF DOCK6 MAST3	1.61e-04	191	137	7	7070_DN
Drug	thapsigargin; Down 200; 0.1uM; MCF7; HT_HG-U133A	GMIP FANCA COL18A1 SALL2 UBAP2L TMUB2 MAST3	1.61e-04	191	137	7	7100_DN
Drug	17-AAG; Down 200; 1uM; ssMCF7; HG-U133A	C11orf24 GMIP ZNF512B TBC1D16 AATK RIPOR1 MAST3	1.61e-04	191	137	7	521_DN
Drug	PHA-00846566E [724718-26-7]; Down 200; 10uM; PC3; HT_HG-U133A	SPEG BCL11A PLEKHG6 ZNF358 TMEM70 NR3C2 DMTN	1.61e-04	191	137	7	7086_DN
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A	KIF1A SPN KHSRP PACS1 TMEM70 SCN10A DMTN	1.71e-04	193	137	7	6699_DN
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; PC3; HT_HG-U133A	SPN TBC1D5 TNS2 APLP1 BCL11A RIPOR1 DOCK6	1.71e-04	193	137	7	7364_DN
Drug	CsCl	HCN4 SPN ORAI1 ACAN MUC4 ALPK2	1.76e-04	136	137	6	CID000024293
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	PKP4 CREBZF PACS1 AKAP13 TNKS2 DOCK6 DMTN	1.77e-04	194	137	7	4727_DN
Drug	Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	PER1 ITGB4 TG OSBPL7 MUC5AC DMTN CCDC93	1.77e-04	194	137	7	4117_UP
Drug	15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A	TBC1D5 TNS2 ARMCX2 PPP4R4 UBAP2L NR3C2 DOCK6	1.77e-04	194	137	7	4455_DN
Drug	Bacitracin [1405-87-4]; Up 200; 2.8uM; MCF7; HT_HG-U133A	SPN RAD54L2 PPP4R4 KHSRP PACS1 COL18A1 EHMT1	1.83e-04	195	137	7	7448_UP
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A	TBC1D5 PKP4 PER1 RAD54L2 PLEKHG6 RPUSD2 TNKS2	1.83e-04	195	137	7	2122_DN
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A	PER1 RAD54L2 SLC7A2 AATK TSC22D4 MUC5AC DMTN	1.83e-04	195	137	7	4124_UP
Drug	Prednisolone [50-24-8]; Up 200; 11uM; MCF7; HT_HG-U133A	ITGB4 CREBZF KHSRP PACS1 RIPOR1 MAST3 CCDC93	1.89e-04	196	137	7	7424_UP
Drug	Metyrapone [54-36-4]; Up 200; 17.6uM; HL60; HT_HG-U133A	MAGIX TNS2 PPP4R4 COL18A1 PLEKHG6 ACAN DOCK6	1.89e-04	196	137	7	3070_UP
Drug	Ethamsylate [2624-44-4]; Up 200; 15.2uM; HL60; HT_HG-U133A	ITGB4 PPP4R4 TBC1D16 COL18A1 RIPOR1 DOCK6 IMPG2	1.89e-04	196	137	7	2915_UP
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A	SPN TNS2 ARMCX2 KHSRP PLEKHG6 MTRR MAP3K7	1.89e-04	196	137	7	3724_DN
Drug	Lysergol [602-85-7]; Up 200; 15.8uM; MCF7; HT_HG-U133A	HCN4 BCL11A PPP4R4 SLC7A2 AATK MUC5AC DMTN	1.89e-04	196	137	7	3261_UP
Drug	Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; PC3; HT_HG-U133A	BCL11A KHSRP PACS1 ZNF358 TMEM70 SCN10A DMTN	1.89e-04	196	137	7	7263_UP
Drug	Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A	PCDHA9 DNAJC6 PDLIM5 PPP4R4 CREBZF OSBPL7 MAP3K7	1.89e-04	196	137	7	7520_DN
Drug	Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	PCDHA9 ARMCX2 PDLIM5 SLC7A2 PER3 RIPOR1 IMPG2	1.95e-04	197	137	7	6779_UP
Drug	Natamycin [7681-93-8]; Up 200; 6uM; HL60; HT_HG-U133A	SPN PER1 DNAJC6 ITGB4 PER3 CAMKV ACAN	1.95e-04	197	137	7	6126_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A	TBC1D5 PDLIM5 CREBZF KHSRP UBAP2L EHMT1 DOCK6	1.95e-04	197	137	7	4754_DN
Drug	Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; PC3; HT_HG-U133A	SPN TNS2 APLP1 ZNF512B NR3C2 DOCK6 CCDC93	1.95e-04	197	137	7	7249_DN
Drug	Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A	SPEG PER1 APLP1 RAD54L2 ITGB4 PDLIM5 IMPG2	2.01e-04	198	137	7	3402_DN
Drug	Chloramphenicol [56-75-7]; Up 200; 12.4uM; PC3; HT_HG-U133A	SPEG PER1 PDLIM5 CREBZF FANCA OSBPL7 BICC1	2.01e-04	198	137	7	5047_UP
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	TNS2 C11orf24 PDLIM5 ZNF512B COL18A1 DOCK6 CCDC93	2.01e-04	198	137	7	7177_DN
Drug	Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	KIF1A SPEG PER1 BCL11A ITGB4 UBAP2L TSC22D4	2.01e-04	198	137	7	7126_UP
Drug	Chlorhexidine [55-56-1]; Up 200; 8uM; PC3; HG-U133A	SPN PER1 BCL11A COL18A1 CAMKV SCN10A AKAP13	2.01e-04	198	137	7	1942_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	SPN PER1 BCL11A RIPOR1 TSC22D4 DOCK6 MAST3	2.01e-04	198	137	7	7366_DN
Drug	Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A	KIF1A SPN SPEG PER1 GMIP KHSRP ZNF358	2.01e-04	198	137	7	6742_DN
Drug	Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; PC3; HT_HG-U133A	KIF1A SPN FRMPD1 PER1 ITGB4 KHSRP ZNF358	2.01e-04	198	137	7	4193_DN
Drug	Nabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A	SPECC1L RAD54L2 PPP4R4 TG AATK ACAN MUC5AC	2.01e-04	198	137	7	6327_UP
Drug	Urosiol [128-13-2]; Down 200; 10.2uM; PC3; HT_HG-U133A	SPN SPEG APLP1 GMIP ZNF512B SLC4A1AP MAST3	2.01e-04	198	137	7	7243_DN
Drug	Palmatine chloride [3486-67-7]; Up 200; 10.4uM; HL60; HT_HG-U133A	FRMPD1 KHSRP COL18A1 SLC7A2 AATK SCN10A DOCK6	2.01e-04	198	137	7	2138_UP
Drug	Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A	PER1 TNS2 BCL11A ITGB4 PPP4R4 PTPRC MUC4	2.07e-04	199	137	7	5458_UP
Drug	Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A	PER1 APLP1 BCL11A KHSRP CELSR1 SCN10A DOCK6	2.07e-04	199	137	7	6816_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	RAD54L2 PDLIM5 KHSRP PACS1 ACAN ZNF358 RIPOR1	2.07e-04	199	137	7	3860_DN
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	IL10RA SPN BCL11A CREBZF ACAN OSBPL7 MUC4	2.07e-04	199	137	7	3603_UP
Drug	Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SPN C11orf24 RAD54L2 COL18A1 RIPOR1 DOCK6 CCDC93	2.07e-04	199	137	7	6221_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; HL60; HG-U133A	SPN BCL11A CREBZF FANCA CHFR RSRP1 AKAP13	2.07e-04	199	137	7	1391_DN
Drug	thioridazine hydrochloride; Down 200; 1uM; MCF7; HG-U133A	PDLIM5 GTF2F1 ACAN OSBPL7 MTRR AKAP13 MAST3	2.07e-04	199	137	7	422_DN
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; HL60; HG-U133A	SPN BCL11A GMIP CREBZF PIK3C3 MTRR AKAP13	2.07e-04	199	137	7	1738_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A	SPEG APLP1 GSE1 AKAP13 RIPOR1 TNKS2 MAP3K7	2.07e-04	199	137	7	6324_DN
Drug	Glycocholic acid [475-31-0]; Up 200; 8.6uM; HL60; HT_HG-U133A	KIF1A SPN MAGIX CREBZF FANCA COL18A1 DOCK6	2.07e-04	199	137	7	2454_UP
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A	KIF1A BCL11A RAD54L2 PDLIM5 PLEKHG6 ACAN SCN10A	2.07e-04	199	137	7	6624_DN
Drug	Propylthiouracil [51-52-5]; Up 200; 23.4uM; PC3; HT_HG-U133A	HCN4 ITGB4 PDLIM5 OSBPL7 TSC22D4 KLRB1 MAST3	2.07e-04	199	137	7	4076_UP
Drug	Khellin [82-02-0]; Up 200; 15.4uM; PC3; HG-U133A	PKP4 TNS2 ITGB4 ACAN AKAP13 RIPOR1 MAST3	2.13e-04	200	137	7	1922_UP
Drug	D-cycloserine [68-41-7]; Down 200; 39.2uM; PC3; HT_HG-U133A	APLP1 CREBZF TMEM70 AKAP13 RIPOR1 CCDC93 CPSF7	2.13e-04	200	137	7	7134_DN
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	6.21e-05	3	135	2	DOID:9368 (is_marker_for)
Disease	Sarcosine measurement	PCDHGA7 PCDHGA6 PCDHGA8	1.55e-04	23	135	3	EFO_0021668
Disease	eosinophil percentage of leukocytes	TBC1D5 TG BPTF CELSR1 PTPRC GSE1 AKAP13 CX3CL1 MUC5AC ALPK2 MAST3 IL9R	1.70e-04	746	135	12	EFO_0007991
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16 MUC5AC	1.77e-04	24	135	3	DOID:12894 (is_marker_for)
Disease	mental development measurement	PCDHGA7 PCDHGA6 PCDHGA8	2.00e-04	25	135	3	EFO_0008230
Disease	mucinous adenocarcinoma (is_marker_for)	MUC4 MUC5AC	2.06e-04	5	135	2	DOID:3030 (is_marker_for)
Disease	cholangiocarcinoma (is_marker_for)	MUC16 OSBPL7 MUC4 MUC5AC	2.15e-04	64	135	4	DOID:4947 (is_marker_for)
Disease	Heart valve disease	PCDHA9 SPN COL18A1	2.25e-04	26	135	3	C0018824
Disease	biliary tract benign neoplasm (is_marker_for)	MUC4 MUC5AC	4.30e-04	7	135	2	DOID:0050625 (is_marker_for)
Disease	common bile duct neoplasm (is_marker_for)	MUC4 MUC5AC	5.71e-04	8	135	2	DOID:4608 (is_marker_for)
Disease	osteoarthritis, spine, body mass index	PER3 CAMKV	5.71e-04	8	135	2	EFO_0004340, EFO_1000787
Disease	2-hydroxystearate measurement	MUC19 ELFN1	7.32e-04	9	135	2	EFO_0021059
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC5AC	9.13e-04	10	135	2	DOID:10140 (is_marker_for)
Disease	Other specified cardiac arrhythmias	HCN4 SCN10A	1.11e-03	11	135	2	C0348626
Disease	PR domain zinc finger protein 1 measurement	USP4 BSN	1.11e-03	11	135	2	EFO_0801904
Disease	Nodal rhythm disorder	HCN4 SCN10A	1.11e-03	11	135	2	C0264893
Disease	Ectopic rhythm	HCN4 SCN10A	1.11e-03	11	135	2	C1399226
Disease	CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)	HCN4 SCN10A	1.11e-03	11	135	2	C2748542
Disease	Malignant neoplasm of salivary gland	BCL11A ITGB4 FANCA	1.15e-03	45	135	3	C0220636
Disease	Salivary Gland Neoplasms	BCL11A ITGB4 FANCA	1.31e-03	47	135	3	C0036095
Disease	Brugada Syndrome 1	HCN4 SCN10A	1.57e-03	13	135	2	C4551804
Disease	Autosomal Recessive Centronuclear Myopathy	SPEG ORAI1	2.10e-03	15	135	2	C3645536
Disease	Sinus Node Dysfunction (disorder)	HCN4 SCN10A	2.10e-03	15	135	2	C0428908
Disease	Inherited oocyte maturation defect	ASTL FBXO43	2.39e-03	16	135	2	cv:CN238505
Disease	platelet component distribution width	MAGIX TBC1D5 NUP35 COL18A1 PTPRC GSE1 RSRP1 AKAP13 NR3C2 TSC22D4	2.54e-03	755	135	10	EFO_0007984
Disease	loneliness measurement	CAAP1 FNBP4 BPTF AGAP3	2.57e-03	124	135	4	EFO_0007865
Disease	mean platelet volume	SETD1B PCDHGA7 PCDHGA6 TBC1D5 PDLIM5 FANCA ZNF512B PTPRC GSE1 RIPOR1 NR3C2 PCDHGA8	2.58e-03	1020	135	12	EFO_0004584
Disease	otitis media (biomarker_via_orthology)	MUC4 MUC5AC	2.70e-03	17	135	2	DOID:10754 (biomarker_via_orthology)
Disease	pancreatic ductal carcinoma (is_marker_for)	KDM2B MUC4 MUC5AC	2.78e-03	61	135	3	DOID:3587 (is_marker_for)
Disease	response to antiviral drug	SHC4 MAP3K7	3.03e-03	18	135	2	EFO_0010123
Disease	electrocardiography	HCN4 SPEG LRRC4B PDLIM5 ZNF358 SCN10A PROB1 NR3C2	3.12e-03	530	135	8	EFO_0004327
Disease	serum gamma-glutamyl transferase measurement	SPECC1L BPTF GSE1 KDM2B AKAP13 KDF1 BICC1 ALPK2 TP53BP1 DMTN MAST3	3.26e-03	914	135	11	EFO_0004532
Disease	coronary artery disease	ANKRD13B CAAP1 KIF1A HCN4 SPECC1L PDLIM5 ELFN1 RPTOR AKAP13 BSN DOCK6 KDF1 BICC1	3.34e-03	1194	135	13	EFO_0001645
Disease	eosinophil count	TBC1D5 GMIP TG BPTF CELSR1 PTPRC GSE1 AKAP13 KDF1 CX3CL1 MUC5AC ALPK2 TP53BP1 MAST3 IL9R	3.40e-03	1488	135	15	EFO_0004842
Disease	radiation-induced disorder	MUC12 PDLIM5 MAP3K7	3.62e-03	67	135	3	EFO_0009565
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	SPECC1L BPTF TNKS2 KDF1 TP53BP1	3.76e-03	224	135	5	EFO_0004530, EFO_0008317
Disease	gastric ulcer (biomarker_via_orthology)	COL18A1 MUC5AC	4.12e-03	21	135	2	DOID:10808 (biomarker_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	BPTF RSRP1 TNKS2 KDF1 TP53BP1	4.13e-03	229	135	5	EFO_0004639, EFO_0008317
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGA7 PCDHGA6 PCDHGA8	4.27e-03	71	135	3	EFO_0007878, EFO_0007979
Disease	cardiomyopathy (implicated_via_orthology)	JPH2 PDLIM5 COL18A1	4.27e-03	71	135	3	DOID:0050700 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VPADDGTTRSPSIDS	PKP4	501	Q99569
STGTPRPDGPSSATE	AGAP3	551	Q96P47
EAAGPPRASTSSSGS	ELFN1	631	P0C7U0
ESISPGTPRSADSSP	ALPK2	151	Q86TB3
PAGEESPFTGTTTIS	ALPK2	676	Q86TB3
AEEPRGSSLSSESSP	GSE1	71	Q14687
TSRSQPGDGPASEVS	AKAP13	2791	Q12802
PDPSGTAVGDPSTRS	APLP1	216	P51693
PSSSESEGIPSIERS	SPECC1L	366	Q69YQ0
PDIVPALASGSSGST	CAAP1	26	Q9H8G2
PTSSRTSSLGSGGPD	CELSR1	2961	Q9NYQ6
PRGGTSQSDISTLPT	DCAF6	371	Q58WW2
DSSAVPGTALGTEPR	RAD54L2	1211	Q9Y4B4
SEETSPSEGRSPVGC	BPTF	646	Q12830
SPEKDGLGSSPRVTS	SLC7A2	446	P52569
GLESSGVTIATSPSP	BICC1	416	Q9H694
AESPGTSGSPRTAVV	ARMCX2	236	Q7L311
TSGSPRTAVVPGTSA	ARMCX2	241	Q7L311
LSAESRSPDPSGSSA	ASTL	316	Q6HA08
GSGLTRTPSSEEISP	RALBP1	21	Q15311
VLTASDGGDPPRSST	PCDHGA7	211	Q9Y5G6
PKSSSRASVGATGPE	PCDHA9	676	Q9Y5H5
LSPCAGSTERTGEPS	PCDHA9	776	Q9Y5H5
TGEPSASSDSTGKPR	PCDHA9	786	Q9Y5H5
GSSEEPAVPSGTARS	ARHGAP36	496	Q6ZRI8
SREGSTSSSLEPEPD	ARHGAP39	131	Q9C0H5
GSRDSGPPPSTVSEA	CPSF7	321	Q8N684
VLTASDGGKPPRSST	PCDHGA8	211	Q9Y5G5
VRGSPSSETPSPGSD	ANKRD13B	446	Q86YJ7
PPSSSASPGESARLT	IGLV5-37	26	A0A075B6J1
SSPEPGSAGHSRIST	MUC16	266	Q8WXI7
RPETSAPGAETTLTS	MUC16	1911	Q8WXI7
SSPGSTAITKGPRTE	MUC16	4036	Q8WXI7
TEVTSSGRTSIPGPS	MUC16	6986	Q8WXI7
PGATSRGTLTLDTST	MUC16	9086	Q8WXI7
GLSSASTGDTTRLPV	MUC4	2421	Q99102
TPLPVTGLSSASTGD	MUC4	3871	Q99102
SRAGTEPSLPQGSSS	CASKIN1	351	Q8WXD9
SLLVSEGTATPGSSP	FAM189A1	341	O60320
SGSRTIAESAPPGTV	PCDHGA6	351	Q9Y5G7
PSGSASSPLADDSRV	KLHL34	376	Q8N239
PSGEGSRSVTPSEGA	JPH2	516	Q9BR39
STAGSSRSPESEKPG	H1-8	16	Q8IZA3
SGTSAGSSTLRDVVP	NR3C2	346	P08235
SEGPSTSVLPTSAEG	MAGEE1	61	Q9HCI5
TRDEGPSTSVPATPG	MAGEE1	251	Q9HCI5
DPGGPEVTGSRSSST	MAGIX	236	Q9H6Y5
EGPSTSRALGLSESP	MAGEL2	971	Q9UJ55
SSLETSRGTSGPPLT	SPN	156	P16150
TDSLETSTGTTGPPV	SPN	191	P16150
SAETSSRASTPAGPI	MUC20	61	Q8N307
ESRSLDSPTSSPGAG	GMIP	431	Q9P107
SGPAPTTDRGTSTDS	MAPK8IP1	221	Q9UQF2
RSLPESTSAPASGPS	NFKBIE	166	O00221
VVSTTGTGDPPDTAR	MTRR	56	Q9UBK8
APSERSKPLSSGTGE	BSN	741	Q9UPA5
ETPSGSSTTPSSGRP	BSN	1166	Q9UPA5
PTSSDSSGGRVIPDV	BSN	1326	Q9UPA5
ASPAGSERSPSPSST	BSN	1401	Q9UPA5
GLSTASSPEPGTSDL	BCL11A	441	Q9H165
RSSPELPPSGGSTTS	ORAI1	11	Q96D31
SSSINSPDRASGPEG	FAM104A	121	Q969W3
EEEGRSSSSPALPTA	PER1	1271	O15534
TGSPPSESPSRTGSA	PER3	1046	P56645
PGVPSRVSGSKETSS	IGLV11-55	81	A0A075B6I3
RATESSPGVTGTTTP	MUC19	2231	Q7Z5P9
GTTTPSAEESRTTGP	MUC19	2241	Q7Z5P9
EPSATESSTSRPLGE	MUC19	2351	Q7Z5P9
GTTTTAPESRTAGVP	MUC19	7126	Q7Z5P9
TTPPLAGGSSTEDSR	COL18A1	696	P39060
SRGSSVESLPPTSEG	MAP3K7	371	O43318
TGSDSSAPGSSPERS	PHRF1	836	Q9P1Y6
HSGPTLTPRTGSSDV	KIF24	1201	Q5T7B8
REPPVLGDSCSSGSS	IL10RA	351	Q13651
STEQPTATSRGGPTA	MUC5AC	2086	P98088
DSPTSGRPGVTSLTA	PDLIM5	331	Q96HC4
SPSGSQRPSVSDDTG	ITGB4	1356	P16144
RDHVSSTGPASSTGP	ODAD1	646	Q96M63
PSPSAAAGGTESRSS	HCN4	56	Q9Y3Q4
SGLSRDATATPPSSP	PACS1	786	Q6VY07
STTTSDVGTEAPGLP	ACAN	2171	P16112
LPPGDVGVSRSSSAE	PI4K2B	66	Q8TCG2
ESPSTRPSTPSLEGS	PLEKHG6	536	Q3KR16
SPEVRGSISTPEDSG	FBXO43	321	Q4G163
STPSQARGEGSPSEA	C6orf132	726	Q5T0Z8
EKTLSSGEPPGTLTS	CCDC93	431	Q567U6
PTASASSTEPSPAGR	CHFR	186	Q96EP1
PGRSTTGAPSTTADS	HECTD1	256	Q9ULT8
PDSSVRTPGESSAIS	HECTD1	1466	Q9ULT8
RSSSPTAGPSTEGAE	KDM2B	911	Q8NHM5
PAEDSSPGISLSSSR	BLM	1291	P54132
PADRSATPATDGSAT	CAMKV	381	Q8NCB2
TDGSITPATDGSVTP	CAMKV	406	Q8NCB2
TPATDGSVTPATDRS	CAMKV	411	Q8NCB2
GSVTPATDRSATPAT	CAMKV	416	Q8NCB2
SGSPEDTPRSSGASS	DOCK6	176	Q96HP0
DSSESTASRQGGAPP	FRMPD1	721	Q5SYB0
GPRDVSTAEPSATSL	FRMPD1	786	Q5SYB0
GDTSTVSPPAGRSLE	FANCA	1371	O15360
LSASTERPDGSSTPG	DUSP15	256	Q9H1R2
STSASPTLRVGEGAT	DNAJC6	566	O75061
DPAPEKSRASSSGGS	MAST3	871	O60307
SPSRDSSVPGSPSSI	DMTN	16	Q08495
RSSSPASALTPEGEA	SALL2	871	Q9Y467
RADTTTGSAAGPPLS	EHMT1	666	Q9H9B1
SSASSPLSAEGRPSP	KIF1A	1426	Q12756
RPGDAAGPASSSTTA	LRRC4B	526	Q9NT99
ESRDSSGTRGLPPTD	OSBPL7	281	Q9BZF2
DDISSPGLGSTPLTS	NUP35	96	Q8NFH5
TAEGTSIPTSTPSEG	MUC17	3206	Q685J3
SPDSGGLPERSVSLT	KHSRP	181	Q92945
SPGLTDSTAPSSELG	RPUSD2	436	Q8IZ73
RPGTPSAEGGSTSST	GTF2F1	386	P35269
DPGTGASSGTRTPDV	SOHLH1	146	Q5JUK2
TPLPSTSRGTGNSVD	PPP4R4	836	Q6NUP7
GESAGTSRAATPLPS	TSC22D4	201	Q9Y3Q8
GSVSGSSPRSDISQP	FNBP4	426	Q8N3X1
EGPGPETRLSTSLSG	AATK	971	Q6ZMQ8
TVESSSVLSEGPGPS	PLEKHG4	86	Q58EX7
ADGSEPTKTPGRTSS	PIK3C3	151	Q8NEB9
PGGDRASPASSTSSL	SHROOM1	6	Q2M3G4
TAETGSSDPLGTRPQ	SHISA9	391	B4DS77
SSRPSSTGLEDISPT	SETD1B	561	Q9UPS6
PAPPDSEGSRSSSSS	IL9R	421	Q01113
LSSPVPVGDTSTLGD	IMPG2	181	Q9BZV3
SLPSTFASSPRGSEE	KDF1	201	Q8NAX2
PSSATFGSTGRSEPE	PROB1	266	E7EW31
SPATTEGGSLTPVRD	RPTOR	696	Q8N122
GSPQEKDSPSTSRSG	RSRP1	11	Q9BUV0
SDSSLGTPSDGRPEL	TRIP10	296	Q15642
ATPGTDSTGPTPRSS	C11orf24	351	Q96F05
ESRDPGSSGPSSPET	SHC4	121	Q6S5L8
PSPGLTSIVSGTSED	ZNF414	81	Q96IQ9
PSLSSSGSSDGGTRP	USP4	931	Q13107
PTSSEVDRFSPSGSV	ZBTB37	301	Q5TC79
DTAPSRLGTSSGGDP	TMPRSS13	566	Q9BYE2
TPTTPLTGRDGSLAS	UBAP2L	841	Q14157
GSDTLVGTSLDTPPT	SPEG	161	Q15772
RSPGTGTSSEDLAPS	SCN10A	1046	Q9Y5Y9
PRSEPRSQESGGTDT	SCAF1	71	Q9H7N4
PSTPRVSEPSGDSSA	TONSL	906	Q96HA7
ESDSSPPSSSDAGLR	TBC1D16	256	Q8TBP0
ASGSNSPTRSESPEP	CREBZF	11	Q9NS37
VSPGSRETSAATLSP	TEX264	231	Q9Y6I9
GSSSPEAPLRSEDST	TMUB2	151	Q71RG4
SGSPKARTTEGPVDS	TACC2	1311	O95359
TPSREEGGCSLASTP	TP53BP1	321	Q12888
ASRSKLPDGPTGSSE	TP53BP1	1746	Q12888
SGGSTEPTTPDSERP	RALGAPB	726	Q86X10
RSPGATADALSSGPS	TNKS2	816	Q9H2K2
SADTSSGSLSPGSRP	ZNF512B	381	Q96KM6
SSPGPSRSSEAREEL	TXNRD3	41	Q86VQ6
ISSSPSVESLPGGRE	TBC1D5	536	Q92609
VSRASSSSGPSGPVA	TMEM70	36	Q9BUB7
EDSIDSPSARPLSTG	RIPOR1	881	Q6ZS17
SDVPGERSTASTFPT	PTPRC	146	P08575
QPGTRTSTSPGVSED	TG	2266	P01266
SSTLTTEPAAESPGR	TNS2	516	Q63HR2
GTPGTTAVSSNRDPE	nan	416	Q8N7P7
RLASPSGSTSSGLEV	TRIM28	591	Q13263
VSSEGTPSREPVASG	CX3CL1	291	P78423
GSRSTPSPTPVESSD	ZNF358	481	Q9NW07
SGPESSSPSSLPRDV	KLRB1	16	Q12918
TALPGSTTTPGLSER	MUC12	951	Q9UKN1
ARSTTSGLVGESTPS	MUC12	1401	Q9UKN1
SGLVGESTPSRLSPS	MUC12	1406	Q9UKN1
LSPARSTTSGLVGES	MUC12	2481	Q9UKN1
STTSGLVGESTPSRL	MUC12	2486	Q9UKN1
SPARSTTSGLVGEST	MUC12	2956	Q9UKN1
TTSGLVGESTPSRLS	MUC12	2961	Q9UKN1
VGESTPSRLSPSSTE	MUC12	2966	Q9UKN1
ARSTTSGLVGESTPS	MUC12	4041	Q9UKN1
SGLVGESTPSRLSPS	MUC12	4046	Q9UKN1
PSPARSTTSGLVEES	MUC12	4731	Q9UKN1
DATGTTPLPARSTAS	MUC12	5056	Q9UKN1
REGATSPSPPTDATG	SLC4A1AP	11	Q9BWU0